Skip to content

Radial Artery Patency and Bleeding, Efficacy, Adverse evenT Trial

RAP and BEAT Clinical Trial (Radial Artery Patency and Bleeding, Effectiveness, Adverse evenT Trial)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02269449
Acronym
RAPandBEAT
Enrollment
1900
Registered
2014-10-21
Start date
2014-10-31
Completion date
2015-04-30
Last updated
2014-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Percutaneous Coronary Intervention

Keywords

transradial intervention, radial artery

Brief summary

The objectives of this study are to demonstrate the safety and efficacy of the new 6Fr sheath (Glidesheath slender; Terumo, Tokyo,Japan ; GSS) compared with the contemporary 5Fr sheath (Hydrophilic coating sheath from Terumo; Tokyo, Japan (standard of care ; SOC).

Interventions

DEVICE6Fr Glidesheath Slender sheath

6Fr sheath (Glidesheath slender: GSS), which is characterized with the same inner lumen diameter with contemporary 6Fr sheath as well as the sheath outer diameter similar with contemporary 5Fr sheath.

DEVICE5Fr sheath

5Fr Hydrophilic coating sheath from Terumo.

PROCEDUREHemostasis with TR band

Hemostasis is achieved using TR band (TERUMO) Patent hemostasis.

PROCEDUREAny hemostasis procedure

Hemostasis is achieved by any hemostasis of each hospital's routine procedure.

Sponsors

European Cardiovascular Research Center
CollaboratorNETWORK
Duke Clinical Research Institute
CollaboratorOTHER
NPO International TRI Network
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient is able to verbally acknowledge an understanding of the associated risks, benefits and treatment alternatives and he or his legally authorized representative provides written informed consent prior to the randomization, as approved by the appropriate IRB. * Patient who is expected to diagnose by coronary artery angiography or followed by PCI. * Patient must agree to undergo all protocol-required follow-up examinations. * Patient who can accept radial access.

Exclusion criteria

* Patient has other medical illness (e.g., cancer or congestive heart failure) that may cause non-compliance with the protocol, confound the data interpretation or is associated with a limited life expectancy (i.e., less than one year). * Hemodialysis patient * STEMI

Design outcomes

Primary

MeasureTime frame
Radial artery occlusionDay 1
Local bleeding from puncture siteDay 1

Secondary

MeasureTime frame
Radial spasm during the index procedureDay 1
Total Procedure TimeDay 1
Total Amount of Contrast DyeDay 1
Procedure success rateDay 1
Device failure for the assigned sheath introducerDay 1
Pain scoreDay 1
Total Radiation DosesDay 1
Vascular access site complicationDay 1

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026